Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of thyroid cytological material, preanalytical procedures and bio-banking.

Cytopathology : official journal of the British Society for Clinical Cytology·2018
Same author

Malignant peripheral nerve sheath tumour in the nasopharynx of a cow.

Schweizer Archiv fur Tierheilkunde·2013
Same author

[Solitary fibrous tumour of the orbit: clinical, radiological, histological findings and differential diagnosis of an uncommon tumour].

Klinische Monatsblatter fur Augenheilkunde·2012
Same author

[Lymphadenopathy].

Praxis·2009
Same author

Exploration of the APC/beta-catenin (WNT) pathway and a histologic classification system for pulmonary artery intimal sarcoma. A study of 18 cases.

Virchows Archiv : an international journal of pathology·2008
Same author

[Glomangiomatosis on the hand. A case report].

Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...·2008

Related Experiment Video

Updated: Jun 7, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

[Cytologic diagnosis of sarcoma].

B Bode-Lesniewska1

  • 1Institut für Klinische Pathologie, Universitätsspital Zürich , Schmelzbergstr. 12, 8032 Zürich, Schweiz. beata.bode@usz.ch

Der Pathologe
|November 6, 2010
PubMed
Summary

This review explores the use of fine needle biopsy for diagnosing soft tissue sarcomas. It highlights the importance of combining clinical data with cytological findings to improve diagnostic accuracy. The study suggests that cytological features such as cell differentiation and extracellular matrix properties can guide further analysis. Immunohistochemical and molecular techniques are recommended to confirm diagnoses. The authors emphasize the need for a multidisciplinary approach involving pathologists and other medical specialists. The findings indicate that this approach can enhance the accuracy of soft tissue tumor diagnosis.

Keywords:
Cytologic diagnosisSoft tissue tumorsFine needle biopsySarcoma diagnosis

Frequently Asked Questions

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Related Experiment Videos

Last Updated: Jun 7, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Area of Science:

  • Diagnostic cytology
  • Soft tissue pathology
  • Sarcoma diagnosis

Background:

Soft tissue swelling is a frequent clinical finding that can arise from multiple benign and malignant conditions. While sarcomas are uncommon causes, accurate diagnosis remains challenging due to overlapping features with other soft tissue lesions. Fine needle biopsy is widely used for its minimal invasiveness and diagnostic utility in inflammatory and infectious diseases. It is also increasingly applied to primary soft tissue tumors. However, the interpretation of cytologic samples requires integration of clinical and radiological data. Age, gender, lesion size, and location are critical in narrowing the differential diagnosis. Cytological features such as cell differentiation and extracellular matrix characteristics provide initial diagnostic clues. These findings guide further analysis, including immunohistochemistry and molecular techniques. Prior research has shown the importance of multidisciplinary collaboration in soft tissue tumor diagnosis.

Purpose Of The Study:

This review aims to evaluate the feasibility of cytologic diagnosis for primary soft tissue sarcomas. It explores the role of fine needle biopsy in this context and highlights the need for integrating clinical, radiological, and morphological data. The study addresses the diagnostic challenges posed by the rarity of sarcomas and the similarity of their features to non-neoplastic lesions. It emphasizes the importance of accurate clinical data in guiding diagnostic decisions. The purpose also includes identifying the cytological features that aid in differentiating sarcomas from other soft tissue tumors. The review considers the diagnostic value of extracellular matrix properties and cell differentiation patterns. It further examines the utility of immunohistochemical and molecular techniques in confirming cytologic findings. The goal is to provide a framework for improving diagnostic accuracy in soft tissue tumor cases.

Main Methods:

The review approach involves synthesizing evidence from the literature on cytologic diagnosis of soft tissue sarcomas. It includes a comprehensive analysis of fine needle biopsy techniques and their application in diagnosing primary tumors. The study incorporates data on clinical parameters such as patient age, gender, lesion size, and location. It evaluates the role of radiological findings in guiding biopsy procedures and interpreting cytological samples. The review also considers the integration of morphological features with cytological data. Immunohistochemical and molecular methods such as FISH and RT-PCR are analyzed for their diagnostic utility. The study examines the feasibility of performing these analyses on cytological smears, cell blocks, or frozen tissues. The synthesis of findings is based on the authors' interpretation of published literature and clinical experience.

Main Results:

The key findings from the literature suggest that cytologic diagnosis of primary soft tissue sarcomas is feasible with appropriate methodologies. Fine needle biopsy is highlighted as a cost-effective and minimally invasive diagnostic tool. Clinical data, including patient demographics and lesion characteristics, are essential for accurate diagnosis. Cytological features such as cell differentiation and extracellular matrix properties provide initial clues for differential diagnosis. Immunohistochemical and molecular analyses are recommended to confirm cytologic findings. These analyses can be performed on cytological smears, paraffin-embedded cell blocks, or frozen tissues. The literature indicates that a multidisciplinary approach is crucial for accurate diagnosis. The review emphasizes the importance of integrating clinical, radiological, and morphological data to improve diagnostic accuracy.

Conclusions:

The synthesis and implications of the literature indicate that cytologic diagnosis of soft tissue sarcomas is a viable diagnostic approach. The review suggests that fine needle biopsy can be an effective method when combined with clinical and radiological data. The findings support the use of cytological features such as cell differentiation and extracellular matrix properties to guide further analysis. The authors propose that immunohistochemical and molecular techniques are valuable for confirming cytologic diagnoses. The literature underscores the importance of a multidisciplinary approach in soft tissue tumor diagnosis. The study highlights the need for close collaboration between pathologists and other medical specialists. The conclusions emphasize the diagnostic utility of cytological methods in conjunction with other diagnostic tools. The authors suggest that these findings may improve diagnostic accuracy in soft tissue tumor cases.

The main outcome is the feasibility of diagnosing primary soft tissue sarcomas using fine needle biopsy combined with clinical and radiological data.

Cytological features such as cell differentiation and extracellular matrix properties provide initial clues for differential diagnosis.

A multidisciplinary approach is important to integrate clinical, radiological, and morphological findings for accurate diagnosis.

Immunohistochemical and molecular methods like FISH and RT-PCR can be performed on cytological smears or cell blocks.

Clinical data such as age, gender, lesion size, and topography are important for narrowing the differential diagnosis.

The authors suggest that integrating clinical, radiological, and morphological data improves diagnostic accuracy in soft tissue tumor cases.